Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sculpher

Showing results (101-110 of 174) with videos related to

Pageof 18
Sort By:
Heart (British Cardiac Society)|February 6, 2007
Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesisChristian Asseburg, Yolanda Bravo Vergel, Stephen Palmer, et al.
Heart (British Cardiac Society)|April 18, 2013
Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC studySimon Walker, François Girardin, Claire McKenna, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 27, 2021
Program Evaluation of Population- and System-Level Policies: Evidence for Decision MakingSimon Walker, Aimee Fox, James Altunkaya, et al.
Heart (British Cardiac Society)|November 15, 2011
Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacementMaureen Watt, Stuart Mealing, James Eaton, et al.
Pharmacoeconomics|July 13, 2023
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?Nancy J Devlin, Tianxin Pan, Mark Sculpher, et al.
Journal of Health Services Research & Policy|October 5, 2006
Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel diseaseGerald Richardson, Mark Sculpher, Anne Kennedy, et al.
Plos One|February 11, 2025
Health-related quality of life implications of plantar ulcers resulting from neuropathic damage caused by leprosy: An analysis from the trial of autologous blood products (TABLE trial) in NepalNaomi Kate Gibbs, Jessica Ochalek, Indra Bahadur Napit, et al.
Health Policy (Amsterdam, Netherlands)|August 28, 2009
Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendationsHelen Weatherly, Michael Drummond, Karl Claxton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2009
Patient characteristics impacting health state index scores, measured by the EQ-5D of females with stress urinary incontinence symptomsDouglas Tincello, Mark Sculpher, Ralf Tunn, et al.
Health Technology Assessment (Winchester, England)|February 19, 2015
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness thresholdKarl Claxton, Steve Martin, Marta Soares, et al.
Pageof 18

Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
Heart (British Cardiac Society)|February 6, 2007
Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesisChristian Asseburg, Yolanda Bravo Vergel, Stephen Palmer, et al.
Heart (British Cardiac Society)|April 18, 2013
Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC studySimon Walker, François Girardin, Claire McKenna, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 27, 2021
Program Evaluation of Population- and System-Level Policies: Evidence for Decision MakingSimon Walker, Aimee Fox, James Altunkaya, et al.
Heart (British Cardiac Society)|November 15, 2011
Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacementMaureen Watt, Stuart Mealing, James Eaton, et al.
Pharmacoeconomics|July 13, 2023
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?Nancy J Devlin, Tianxin Pan, Mark Sculpher, et al.
Journal of Health Services Research & Policy|October 5, 2006
Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel diseaseGerald Richardson, Mark Sculpher, Anne Kennedy, et al.
Plos One|February 11, 2025
Health-related quality of life implications of plantar ulcers resulting from neuropathic damage caused by leprosy: An analysis from the trial of autologous blood products (TABLE trial) in NepalNaomi Kate Gibbs, Jessica Ochalek, Indra Bahadur Napit, et al.
Health Policy (Amsterdam, Netherlands)|August 28, 2009
Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendationsHelen Weatherly, Michael Drummond, Karl Claxton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2009
Patient characteristics impacting health state index scores, measured by the EQ-5D of females with stress urinary incontinence symptomsDouglas Tincello, Mark Sculpher, Ralf Tunn, et al.
Health Technology Assessment (Winchester, England)|February 19, 2015
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness thresholdKarl Claxton, Steve Martin, Marta Soares, et al.
Pageof 18